Allena Pharmaceuticals' IPO

Allena Pharmaceuticals raised a round of funding on November 02, 2017. Investors include Public.

Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions. The c…

Articles about Allena Pharmaceuticals' IPO: